Sort by
Refine Your Search
-
Listed
-
Employer
- Delft University of Technology (TU Delft)
- Delft University of Technology (TU Delft); Delft
- University of Groningen
- Eindhoven University of Technology (TU/e)
- Eindhoven University of Technology (TU/e); Eindhoven
- Leiden University
- Radboud University Medical Center (Radboudumc)
- University of Twente (UT)
- Delft University of Technology (TU Delft); 26 Sep ’25 published
- Delft University of Technology (TU Delft); yesterday published
- Leiden University; 's-Gravenhage
- Maastricht University (UM)
- Maastricht University (UM); 26 Sep ’25 published
- NIOZ Royal Netherlands Institute for Sea Research
- Nature Careers
- Princess Máxima Center for Pediatric Oncology
- Princess Máxima Center for Pediatric Oncology; Utrecht
- Radboud University Medical Center (Radboudumc); Nijmegen
- University Medical Center Utrecht (UMC Utrecht)
- University Medical Center Utrecht (UMC Utrecht); Utrecht
- University of Amsterdam (UvA)
- University of Amsterdam (UvA); Amsterdam
- University of Groningen; Groningen
- University of Twente
- Wageningen University & Research
- 15 more »
- « less
-
Field
-
, you will work at the intersection of data science, epidemiology, and clinical research, developing innovative methods to optimize the use of rich real-world data. You will be part of a collaborative
-
obtained ScanNanoTreat (SNT) EIC transition grant. Specific tasks are 1) in vitro evaluation of nanohybrid toxicity and X-ray dose optimization in cancer and healthy cells, 2) optimization of intratumoral
-
models for optimized selection of treatment before, and follow-up after EVAR. You will implement and advance multimodal deep learning models combining CT imaging and clinical data, trained on the unique
-
profitability. Examples include optimizing production speeds to balance output, equipment deterioration, and energy consumption in manufacturing, or designing dynamic pricing and allocation policies in rental
-
cancer, in a single location in Utrecht. Our institute aims to provide the highest level of care for all children with cancer, with optimal quality of life. The center brings together the best possible
-
strategies (e.g. predictive or machine learning approaches) to improve performance and reduce costs. Collaborating with industrial partners on design optimization, life-cycle analysis, and business case
-
on design optimization, life-cycle analysis, and business case development. Publishing results in journals and conferences, and engaging with stakeholders through workshops and demonstrations. The position is
-
, develop innovative therapeutic strategies, and optimize drug delivery to improve human health. Our teams combine expertise in nanomedicine, RNA biology, organoid models, and the tissue microenvironment
-
to provide the highest level of care for all children with cancer, with optimal quality of life. The center brings together the best possible care and scientific research, creating a unique interdisciplinary
-
/pharmaceutical-technology-and-biopharmacy/ ). Researchers at GRIP aim to understand the molecular basis of disease, develop innovative therapeutic strategies, and optimize drug delivery to improve human health